opsonization

出典: meddic

オプソニン作用

WordNet   license wordnet

「process whereby opsonins make an invading microorganism more susceptible to phagocytosis」
opsonisation

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

英文文献

  • Cell source determines the immunological impact of biomimetic nanoparticles.
  • Evangelopoulos M1, Parodi A2, Martinez JO1, Yazdi IK1, Cevenini A3, van de Ven AL1, Quattrocchi N1, Boada C4, Taghipour N1, Corbo C1, Brown BS1, Scaria S1, Liu X1, Ferrari M1, Tasciotti E5.
  • Biomaterials.Biomaterials.2016 Mar;82:168-77. doi: 10.1016/j.biomaterials.2015.11.054. Epub 2015 Dec 2.
  • Recently, engineering the surface of nanotherapeutics with biologics to provide them with superior biocompatibility and targeting towards pathological tissues has gained significant popularity. Although the functionalization of drug delivery vectors with cellular materials has been shown to provide
  • PMID 26761780
  • A galectin related protein from Oplegnathus fasciatus: Genomic, molecular, transcriptional features and biological responses against microbial pathogens.
  • Thulasitha WS1, Whang I2, Umasuthan N1, Kang HS3, Mothishri MS1, Lee S1, Qiang W1, Noh JK4, Lee J5.
  • Developmental and comparative immunology.Dev Comp Immunol.2016 Mar;56:13-24. doi: 10.1016/j.dci.2015.11.011. Epub 2015 Nov 22.
  • Galectins, a family of β-galactoside-binding lectins, are pattern recognition receptors that recognize pathogen-associated molecular patterns and are subsequently involved in the opsonization, phagocytosis, complement activation, and killing of microbes. Here, we report a novel galectin related pro
  • PMID 26615008
  • The clinical potential of Affibody-based inhibitors of C5 for therapeutic complement disruption.
  • Berglund MM1, Strömberg P1.
  • Expert review of proteomics.Expert Rev Proteomics.2016 Feb 3. [Epub ahead of print]
  • The awareness of the complement system as an important target area for therapeutic intervention has increased over the last decade, primarily due to the successful introduction of the C5 inhibiting mAb eculizumab (Soliris®, Alexion Pharmaceuticals Inc.) in the treatment of the ultra-rare conditions
  • PMID 26837283

和文文献

  • Global Control of Pneumococcal Infections by Pneumococcal Vaccines
  • , ,
  • Tropical Medicine and Health 42(2SUPPLEMENT), S83-S86, 2014
  • Streptococcus pneumoniae is a major worldwide cause of morbidity and mortality. Pneumococcal carriage is considered to be an important source of horizontal spread of this pathogen within the community …
  • NAID 130004463461
  • 補体系の役割と臨床医学でのトピックス
  • 若宮 伸隆
  • 臨床病理 60(8), 779-785, 2012-08-25
  • … First is an opsonization following the phagocytosis and elimination of microbes. …
  • NAID 10031123890
  • C3 Glomerulonephritis Associated with a Missense Mutation in the Factor H Gene
  • , , , ,
  • The Tohoku Journal of Experimental Medicine 227(3), 211-215, 2012
  • … a conformational change of C3 molecules by C3 convertases leads to an enzyme complex formation resulting in opsonization and cell lysis. …
  • NAID 130004459991

関連リンク

関連画像


押しても画像が表示されない場合はサーバが混雑しています。2週間ほどあけて、再度押下してください。


★リンクテーブル★
リンク元opsonize」「オプソニン作用」「opsonophagocytic」「オプソニン化

opsonize」

  [★]

  • v.
  • オプソニン化する
opsonization

WordNet   license wordnet

「make (cells) more susceptible to the action of phagocytes」

オプソニン作用」

  [★]

opsonization
オプソニン



opsonophagocytic」

  [★]

オプソニン作用の

opsonization

オプソニン化」

  [★]

opsonization
オプソニン




★コメント★

[メモ入力エリア]
※コメント5000文字まで
ニックネーム:
コメント:




表示
個人用ツール


  meddic.jp

リンク
連絡